SAS vs. SAS vs. Phoenix [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-12 14:01 (1478 d 05:06 ago) – Posting: # 20788
Views: 7,575

Hi to all victims of the partial replicate with incomplete data,

following extensive off-list discussions with PharmCat (who is working on a Julia-library; see here and there) I checked again what we got with the FDA’s covariance structure, Satterthwaite’s df (PE, 90% CI).
Not the slightest idea how I arrived at the results given above. Sorry for the confusion caused.
In all cases simplifying the covariance structure (in SAS-lingo FA0(1) instead of the FA0(2) in the guidance): Convergence without warning.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,639 registered users;
11 visitors (0 registered, 11 guests [including 4 identified bots]).
Forum time: 19:07 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz